Home > NRC Library > ADAMS Public Documents

06-28799-01 602597 Alexion Pharmaceuticals, Inc.

Accession Number: ML18074A205

Date Released: Monday, April 30, 2018

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML18074A206 - Alexion Pharmaceuticals, Inc.; Amendment Request Letter dtd March 5, 2018. (37 page(s), 3/5/2018)
• ML18107A658 - Alexion Pharmaceuticals, Inc., Telephone Conversation Record dated 04/09/18, Subject Release of Areas. (1 page(s), 4/9/2018)
• ML18110A261 - Alexion Pharmaceuticals, Inc.; Cover Letter dtd April 11, 2018, for License Amendment No. 21; Control No. 602597. (3 page(s), 4/11/2018)
• ML18110A263 - Alexion Pharmaceuticals, Inc.; License Amendment No. 21; Control No. 602597. (2 page(s), 4/11/2018)